Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    Discontinuing prophylaxis against recurrent opportunistic infections in HIV-infected persons: a victory in the era of HAART.

    Kaplan JE, Masur H, Holmes KK.

    Ann Intern Med. 2002 Aug 20;137(4):285-7. No abstract available. PMID: 12186519 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections]

    Pozio E.

    Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian. PMID: 15305694 [PubMed - indexed for MEDLINE]Related articles

    3.

    Discontinuing prophylaxis against Pneumocystis carinii pneumonia.

    Le Moal G, Breux JP, Roblot F.

    N Engl J Med. 2001 May 24;344(21):1639-41. No abstract available. PMID: 11374363 [PubMed - indexed for MEDLINE]Related articles

    4.

    Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.

    Esposito S, Bojanin J, Porta A, Cesati L, Gualtieri L, Principi N.

    Pediatr Infect Dis J. 2005 Dec;24(12):1117-20.PMID: 16371882 [PubMed - indexed for MEDLINE]Related articles

    5.

    A case of pneumocystis pneumonia after cessation of secondary prophylaxis.

    Quah SP, McBride M.

    Int J STD AIDS. 2001 Feb;12(2):126-7.PMID: 11236102 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Approach to opportunistic illness in the HAART era]

    Imamura A.

    Nippon Rinsho. 2002 Apr;60(4):757-62. Review. Japanese. PMID: 11968784 [PubMed - indexed for MEDLINE]Related articles

    8.

    Opportunistic infections: an update.

    Furrer H, Fux C.

    J HIV Ther. 2002 Feb;7(1):2-7. Review.PMID: 11956497 [PubMed - indexed for MEDLINE]Related articles

    9.

    Summaries for patients. Can maintenance therapy for opportunistic infections in HIV-infected people be stopped safely?

    [No authors listed]

    Ann Intern Med. 2002 Aug 20;137(4):I34. No abstract available. PMID: 12186538 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

    Losina E, Yazdanpanah Y, Deuffic-Burban S, Wang B, Wolf LL, Messou E, Gabillard D, Seyler C, Freedberg KA, Anglaret X.

    Antivir Ther. 2007;12(4):543-51.PMID: 17668563 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.

    Mammen-Tobin A, Monteiro EF.

    Int J STD AIDS. 2000 Jan;11(1):64-5. No abstract available. PMID: 10667904 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.

    Lim L, Street AC, Lewin SR.

    AIDS. 2001 Sep 28;15(14):1912-3. No abstract available. PMID: 11579267 [PubMed - indexed for MEDLINE]Related articles

    13.

    Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.

    Nesheim SR, Kapogiannis BG, Soe MM, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.

    Pediatrics. 2007 Jul;120(1):100-9.PMID: 17606567 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

    Berenguer J, Laguna F, López-Aldeguer J, Moreno S, Arribas JR, Arrizabalaga J, Baraia J, Casado JL, Cosín J, Polo R, González-García J, Iribarren JA, Kindelán JM, López-Bernaldo de Quirós JC, López-Vélez R, Lorenzo JF, Lozano F, Mallolas J, Miró JM, Pulido F, Ribera E.

    Enferm Infecc Microbiol Clin. 2004 Mar;22(3):160-76. Review. English, Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2004 Nov;22(5):271. PMID: 14987537 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy.

    Hung CC, Hsieh SM, Hsiao CF, Chen MY, Sheng WH.

    AIDS. 2001 Mar 30;15(5):645-7. No abstract available. PMID: 11317004 [PubMed - indexed for MEDLINE]Related articles

    16.

    Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.

    Lilleri D, Piccinini G, Baldanti F, Seminari E, Galloni D, Gerna G.

    J Clin Virol. 2003 Jan;26(1):95-100.PMID: 12589839 [PubMed - indexed for MEDLINE]Related articles

    18.

    Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection.

    Liao CH, Chen MY, Hsieh SM, Sheng WH, Hung CC, Chang SC.

    J Microbiol Immunol Infect. 2004 Feb;37(1):50-6.PMID: 15060688 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.

    Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, Quillet C, Fontanet A.

    AIDS. 2007 Jan 30;21(3):351-9.PMID: 17255742 [PubMed - indexed for MEDLINE]Related articles

    20.

    Discontinuing prophylaxis against Pneumocystis carinii pneumonia.

    Bender MA, Sax PE.

    N Engl J Med. 2001 May 24;344(21):1639; author reply 1640-1. No abstract available. PMID: 11374364 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data